Ablation treatments in unresectable pancreatic cancer
- PMID: 30600963
- DOI: 10.23736/S0026-4733.18.07881-1
Ablation treatments in unresectable pancreatic cancer
Abstract
Ablation treatments have been increasingly applied as an alternative treatment for unresectable locally advanced pancreatic cancer (LAPC). The goal of LAPC therapy is surgical resection with negative margins (R0); however, that can be achieved only in a minority of patients and only following neoadjuvant treatment. Ablation might be useful for those patients with unresectable LAPC that do not progress towards metastatic stage and do not experience a true downstaging. Indeed, some LAPC that tend to grow locally, might be the subgroup of tumors that could benefit from ablation. Experience is necessary to select patients and the technique to adopt, since serious or fatal complications can occur. This review aims to discuss the role of ablation treatments in LAPC, with a unique focus on radiofrequency ablation and irreversible electroporation.
Similar articles
-
Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.Cancer Med. 2020 Jul;9(13):4699-4710. doi: 10.1002/cam4.3119. Epub 2020 May 15. Cancer Med. 2020. PMID: 32410380 Free PMC article.
-
Locally advanced pancreatic cancer: An emerging entity.Curr Probl Cancer. 2018 Jan-Feb;42(1):12-25. doi: 10.1016/j.currproblcancer.2017.10.006. Epub 2017 Nov 16. Curr Probl Cancer. 2018. PMID: 29153290 Review.
-
Multi-disciplinary management of locally advanced pancreatic cancer with irreversible electroporation.J Surg Oncol. 2017 Jul;116(1):35-45. doi: 10.1002/jso.24640. Epub 2017 May 5. J Surg Oncol. 2017. PMID: 28475814 Review.
-
Irreversible electroporation of locally advanced pancreatic cancer.Semin Oncol. 2021 Feb;48(1):84-94. doi: 10.1053/j.seminoncol.2021.02.004. Epub 2021 Feb 18. Semin Oncol. 2021. PMID: 33648735 Review.
-
Ablation Strategies for Locally Advanced Pancreatic Cancer.Dig Surg. 2016;33(4):351-9. doi: 10.1159/000445021. Epub 2016 May 25. Dig Surg. 2016. PMID: 27216160 Review.
Cited by
-
Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer.Cancers (Basel). 2023 Nov 25;15(23):5577. doi: 10.3390/cancers15235577. Cancers (Basel). 2023. PMID: 38067280 Free PMC article. Review.
-
Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation.Pathol Oncol Res. 2023 May 30;29:1611175. doi: 10.3389/pore.2023.1611175. eCollection 2023. Pathol Oncol Res. 2023. PMID: 37325466 Free PMC article.
-
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine.Ann Oncol. 2021 Feb;32(2):183-196. doi: 10.1016/j.annonc.2020.11.013. Epub 2020 Nov 26. Ann Oncol. 2021. PMID: 33248227 Free PMC article. Review.
-
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer.Endosc Int Open. 2020 Oct;8(10):E1511-E1519. doi: 10.1055/a-1221-9879. Epub 2020 Oct 7. Endosc Int Open. 2020. PMID: 33043122 Free PMC article.
-
Possible involvement of HSP70 in pancreatic cancer cell proliferation after heat exposure and impact on RFA postoperative patient prognosis.Biochem Biophys Rep. 2019 Oct 31;20:100700. doi: 10.1016/j.bbrep.2019.100700. eCollection 2019 Dec. Biochem Biophys Rep. 2019. PMID: 31867446 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical